Medicines Access

We deliver pre-approval access programs and unlicensed
medicines helping patients in need all over the world.

Access programs and unlicensed medicines

When patients have a life threatening or debilitating illness, and their physicians have exhausted current treatment options, there simply aren’t any available or they are unable to enter a clinical trial, mechanisms exist across the globe to enable access to pre-approval or unlicensed medicines. Healthcare professionals often seek to access these medicines and biopharma companies with medicines that may help, are often compelled to offer access for these patients. 

Consulting and delivery

We provide Medicines Access solutions in consulting, advising, designing, implementing and delivering pre-approval and medicines access programs, whilst also supporting healthcare professionals to access pre-approval and unlicensed medicines for patients in need.

We help patients get access to treatment
  • Pre-approval programs
  • Unlicensed medicines
  • Un-met medical need
  • Regulatory support
  • Healthcare support
We run access programs
  • Designed to meet needs of medicine, company, and patients
  • Fully outsourced or in collaboration
  • Navigation of regulations and customs requirements
  • Personal service and project management
  • Global infrastructure and capabilities
Consulting services to biotechs and pharma
  • Strategies and policies
  • Education and insights
  • Feasibility and pre-programs
  • RWE evidence
  • Compliant communications
Supporting HCPs
  • Responsive key account management
  • Pre-approvals and unlicensed medicines supply
  • Providing access globally
  • Supporting local regulatory and logistics requirements
  • Imap online access portal
  • Rapid, bespoke service

Our experts have implemented over 200 access programs across all stages of the drug lifecycle, and supported healthcare professionals across the globe in accessing critical treatments for patients in need.

We work with biotech and pharma companies of all sizes to design programs which meet your global requirements.  As a team of leading experts in access to medicines, we design strategies and programs to match your objectives and the patients’ need.

Our programs are powered by an understanding of need and delivered with compassion for patients. We understand the importance of your clinical development program, and ensure that any access program delivers for both the patients and physicians.

We have experience in sourcing and supplying products for 20 years. We work with healthcare professionals across the world to assist them in accessing critical treatments not available or approved in their respective countries for their patients with high unmet medical need.

Our Experts

We are here to help you


Mark has significant experience in implementing global access programs and leads our Medicines Access unit.

Mark Corbett



With a background in practicing medicine, Maria oversees all activity to ensure that patient safety remains at the core of our operations.

Maria Eklind-Cervenka



With over 20 years of industry experience, Stuart leads the consulting arm of our Medicines Access team.

Stuart Bell

Vice President Consulting,
Medicines Access


With a background in pharmacology and project management, Ruth leads the implementation of our pre-approval access programs.

Ruth Rostron

Head of Project Management,
Medicines Access


Industry expert in supply chain management. Annika leads our quality team and ensures best-in-class supply chain solutions for our clients.

Annika Kollén



Andrew has experience in international sales and leadership, with a focus on unlicensed medicines and pre-approval access.

Andrew Cummins

Vice President Healthcare,
Medicines Access


Sarah is experienced in medical affairs and her background has a key focus on improving access to treatment for patients.

Sarah Fry

Global Business Development Manager,
Medicines Access

Clive Whitcher


We are here to help by providing vital advisory and practical support for the biopharmaceutical industry, healthcare professionals, and patient advocacy groups.

Clinical Trial Services

Learn More

Commercial Products

Learn More